Retracted: MiR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting …
L Yu, H Li, W Liu, L Zhang, Q Tian… - Molecular genetics & …, 2021 - Wiley Online Library
Abstract Background Numerous microRNAs (miRNAs) have been identified as functional
molecules in Alzheimer's disease (AD) pathogenesis. This study aimed to investigate the …
molecules in Alzheimer's disease (AD) pathogenesis. This study aimed to investigate the …
[HTML][HTML] MicroRNA-511-3p regulates Aβ1–40 induced decreased cell viability and serves as a candidate biomarker in Alzheimer's disease
T Wang, W Zhao, Y Liu, D Yang, G He, Z Wang - Experimental Gerontology, 2023 - Elsevier
Background Alzheimer's disease (AD) is a progressive neurodegenerative disease with high
incidence in the elderly population. MicroRNAs have been reported to abnormally …
incidence in the elderly population. MicroRNAs have been reported to abnormally …
Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and …
Q Liu, C Lei - Experimental Gerontology, 2021 - Elsevier
Background Alzheimer's disease (AD) is a common neurodegenerative disease with an
increasing incidence rate. Numerous microRNAs (miRNAs) have been found to be involved …
increasing incidence rate. Numerous microRNAs (miRNAs) have been found to be involved …
The emerging role of microRNA-4487/6845-3p in Alzheimer's disease pathologies is induced by Aβ25–35 triggered in SH-SY5Y cell
Background Accumulation of amyloid β-peptide (Aβ) is implicated in the pathogenesis and
development of Alzheimer's disease (AD). Neuron-enriched miRNA was aberrantly …
development of Alzheimer's disease (AD). Neuron-enriched miRNA was aberrantly …
Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity
H Zhang, W Liu, H Ge, K Li - Neuroscience letters, 2021 - Elsevier
Objective The current study investigated the expression change and clinical value of miR-
148a-3p in AD patients, and further examined the role of miR-148a-3p in Aβ-induced …
148a-3p in AD patients, and further examined the role of miR-148a-3p in Aβ-induced …
MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein …
W Wan, G Liu, X Li, Y Liu, Y Wang, H Pan, J Hu - Bioengineered, 2021 - Taylor & Francis
Alzheimer's disease (AD) is a progressive neurodegenerative disease. Multiple reports have
elucidated that microRNAs are promising biomarkers for AD diagnosis and treatment …
elucidated that microRNAs are promising biomarkers for AD diagnosis and treatment …
Targeting MicroRNA-485-3p blocks Alzheimer's disease progression
HS Koh, SJ Lee, HJ Lee, JW Min, T Iwatsubo… - International journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is a form of dementia characterized by progressive memory
decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment …
decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment …
Retracted: Effect of microRNA‐186 on oxidative stress injury of neuron by targeting interleukin 2 through the janus kinase‐signal transducer and activator of …
DM Wu, X Wen, YJ Wang, XR Han, S Wang, M Shen… - 2018 - Wiley Online Library
Recent studies have proposed that microRNAs (miR) function as novel diagnostic and
prognostic biomarkers and therapeutic targets in Alzheimer's disease (AD), a common …
prognostic biomarkers and therapeutic targets in Alzheimer's disease (AD), a common …
Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2
R Wang, J Zhang - Experimental gerontology, 2020 - Elsevier
Abstract Background Numerous microRNAs (miRNAs) have been investigated in the
progression of Alzheimer's disease (AD). The purpose of this study was to analyze the …
progression of Alzheimer's disease (AD). The purpose of this study was to analyze the …
[HTML][HTML] MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis
S Li, L Wu, M Ma, L Yang, C Qin - Annals of Translational Medicine, 2022 - ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the most common type of dementia in old age and
has become a serious social and medical problem threatening human health. We aimed to …
has become a serious social and medical problem threatening human health. We aimed to …
相关搜索
- alzheimer's disease cell viability
- marker expression cell viability
- alzheimer's disease marker expression
- candidate biomarker cell viability
- alzheimer's disease 148a 3p
- alzheimer's disease candidate biomarker
- alzheimer's disease neuroprotective effects
- alzheimer's disease response of microglia
- neuroprotective effects cell viability
- alzheimer's disease amyloid β
- diagnosis and severity cell viability
- alzheimer's disease 181c 5p
- alzheimer's disease diagnosis and severity
- alzheimer's disease clinical significance
- alzheimer's disease aberrant expression